News & Updates
Filter by Specialty:
New HF guideline: Quad therapy, HFmrEF, and more
04 May 2022
byElvira Manzano
Hot on the heels of ACC.22 ground-breaking reports, the ACC/AHA/HFSA* released the 2022 heart failure (HF) guideline, with special emphasis on quad therapy for patients with reduced ejection fraction.
New HF guideline: Quad therapy, HFmrEF, and more
04 May 2022Dapagliflozin most effective in frail patients with heart failure
28 Apr 2022
Treatment with dapagliflozin results in improvements in all outcomes, regardless of frailty status, among patients with symptomatic heart failure (HF) with reduced ejection fraction, reports a study. However, “more frail” patients have larger absolute reductions.